Tong Ren Tang Technologies Co. Ltd. (HKG:1666)
Hong Kong · Delayed Price · Currency is HKD 4.020
+0.030 (0.75%)
At close: Mar 27, 2026
HKG:1666 Revenue
In the year 2025, Tong Ren Tang Technologies had annual revenue of 6.48B CNY, down -10.69%. Tong Ren Tang Technologies had revenue of 2.75B in the half year ending December 31, 2025, a decrease of -2.89%.
Revenue
6.48B CNY
Revenue Growth
-10.69%
P/S Ratio
0.71
Revenue / Employee
1.67M CNY
Employees
3,888
Market Cap
5.15B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.48B | -775.77M | -10.69% |
| Dec 31, 2024 | 7.26B | 486.18M | 7.18% |
| Dec 31, 2023 | 6.77B | 781.62M | 13.04% |
| Dec 31, 2022 | 5.99B | 591.35M | 10.95% |
| Dec 31, 2021 | 5.40B | 793.12M | 17.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 81.73B |
| BeOne Medicines AG | 41.59B |
| Innovent Biologics | 14.51B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Beauty Farm Medical and Health Industry | 3.17B |
| Bayzed Health Group | 1.31B |
| Yidu Tech | 812.73M |
| LEPU ScienTech Medical Technology (Shanghai) | 605.14M |
Tong Ren Tang Technologies News
- 7 weeks ago - Chinese Medicine Firm Seeks Elusive Elixir Of IPO Success - Benzinga